Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

STOCK BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2018

A summary of the stock option activity and related information for the Plans for the three months ended March 31, 2018 is as follows:

	Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term
Outstanding at January 1, 2018		401,724	$	39.81		8.35
Grants		834,634	$	3.70
Exercised		-
Forfeitures or expirations		-	$	-
Outstanding at March 31, 2018		1,236,358	$	15.43		9.20

Vested and expected to vest at March 31, 2018		1,236,358	$	15.43		9.20
Exercisable at March 31, 2018		178,810	$	76.27		6.99

The assumptions used in the valuation of stock options granted during the three months ended March 31, 2018 and 2017 were as follows:

	Three Months Ended March 31, 2018		Three Months Ended March 31, 2017
Risk-free interest rate		2.54% to 2.79%		1.99% to 2.29%
Expected term of option		4.50 to 7.00 years		5.00 to 7.91 years
Expected stock price volatility		101.74% to 102.00%		76.61% to 76.77%
Expected dividend yield		0.0		0.0